United States Health Information Knowledgebase

 

Functional Groups

Functional Groups provide views of the data elements, value sets, and other metadata attributes by different views defined by the organization. For USHIK, these include Model Views that correspond to Modules, Components, IS and other groupings. The user can view the items in the functional group, inspect any of the items individually, download the group or item, compare or mark for comparison items in the group, then move seamlessly to related groups, related items, and other links of use to the customer.

Results 1 - 50 of 6387
Compare/Download Selected

SortItem
SortOrganization
Organization(s) Selected
SortStatus
Status(s) Selected
SortType
Type(s) Selected
Ischemic or hemorrhagic stroke patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given on the day of or the day after hospital admission HITSP Recorded Calculation
Ischemic or hemorrhagic stroke patients HITSP Recorded Calculation
Ischemic stroke patients prescribed antithrombolytic therapy at hospital discharge HITSP Recorded Calculation
Ischemic stroke patients HITSP Recorded Calculation
Ischemic stroke patients prescribed anticoagulation therapy at hospital discharge HITSP Recorded Calculation
Ischemic stroke patients with documented atrial fibrillation/flutter HITSP Recorded Calculation
Acute ischemic stroke patients for whom IV thrombolytic therapy was initiated at this hospital within 3 hours (<= 180 minutes) of time last known well HITSP Recorded Calculation
Acute ischemic stroke patients whose time of arrival is within 2 hours (< =120 minutes) of time last known well HITSP Recorded Calculation
Ischemic stroke patients who had antithrombolytic therapy administered by end of hospital day 2 HITSP Recorded Calculation
Ischemic stroke patients (Stroke 5) HITSP Recorded Calculation
Ischemic stroke patients prescribed statin medication at hospital discharge HITSP Recorded Calculation
Ischemic stroke patients with an LDL >= 100 mg/dL, OR LDL not measured, OR who were on a lipid-lowering medication prior to hospital arrival HITSP Recorded Calculation
Ischemic or hemorrhagic STK pats w/docs that they or their caregivers were given ed material addressing the following 1. Activation of emer med sys 2. Need for follow-up after disch 3. Meds prescr d @disch 4. Risk factors for STK 5. Warning signs for STK HITSP Recorded Calculation
Ischemic stroke or hemorrhagic stroke patients discharged home HITSP Recorded Calculation
Ischemic or hemorrhagic stroke patients assessed for or who received rehabilitation services HITSP Recorded Calculation
Ischemic or hemorrhagic stroke patients Stroke 10 HITSP Recorded Calculation
Patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or day after hospital admission the day of or day after surgery end date for surgeries that start the day of or day after hospital admission HITSP Recorded Calculation
All patients HITSP Recorded Calculation
Patients who received VTE prophylaxis or have documentation why noVTE prophylaxis was given the day of or day after hospital admission the day of or day after surgery end date for surgeries that start the day of or day after hospital admission HITSP Recorded Calculation
All patients ICU VTE HITSP Recorded Calculation
Patients who rec d VTE prophylaxis or have documentation why no VTE prophylaxis was given: the day of or the day after ICU admit(or xfer) the day of or the day after surgery end date for surgeries that start the day of or the day after ICU admit(or xfer) HITSP Recorded Calculation
Patients who received overlap therapy HITSP Recorded Calculation
Patients with confirmed VTE who received warfarin HITSP Recorded Calculation
Patients who have their IV UFH therapy dosages AND platelet counts monitored according to defined parameters such as a nomogram or protocol HITSP Recorded Calculation
Patients with confirmed VTE receiving IV UFH therapy HITSP Recorded Calculation
Patients with docs. that they or caregvrs were gvn written disch. instrs or other edu. material re: warfarin that addressed the following: 1. compliance issues 2. Dietary advice 3. Follow-up monitoring 4. Potential for adv. drug reactions and interactions HITSP Recorded Calculation
Patients with confirmed VTE discharged on warfarin therapy Patients with confirmed VTE who received warfarin HITSP Recorded Calculation
[All patients in the denominator] (Patients) who received no VTE prophylaxis prior to the VTE diagnostic test order date HITSP Recorded Calculation
Patients who developed confirmed VTE during hospitalization HITSP Recorded Calculation
Median ED Arrival to ED Departure Aggregated by Observation Services, Principal Diagnosis of Psychiatric/Mental Health Patients, Non-Observation/Mental Disorder Patients HITSP Recorded Calculation
Median Admit Decision Time to ED Departure Time Aggregated by Observation Services, Principal Diagnosis of Psychiatric/Mental Health Patients, Non-Observation/Mental Disorder Patients HITSP Recorded Calculation
Problems List S&I Registered CEDD Object
Review of Systems S&I Registered CEDD Object
Social History S&I Registered CEDD Object
Admitting and Discharging Diagnoses S&I Registered CEDD Object
Allergies and Intolerances S&I Registered CEDD Object
Behavioral Health History S&I Registered CEDD Object
Care Team Members S&I Registered CEDD Object
Consult(s) Assessment(s) and Plan(s) Recommendations S&I Registered CEDD Object
Culturally Sensitive Patient Care S&I Registered CEDD Object
Demographics S&I Registered CEDD Object
Diet and Exercise S&I Registered CEDD Object
Encounters S&I Registered CEDD Object
Existence of Advanced Directives S&I Registered CEDD Object
Family History S&I Registered CEDD Object
General Results S&I Registered CEDD Object
Goals S&I Registered CEDD Object
History of Present Illness S&I Registered CEDD Object
Immunization History S&I Registered CEDD Object
Invasive & Non-Invasive Procedures S&I Registered CEDD Object
Results 1 - 50 of 6387
Scroll To Top